Mental health services, use

Bums, B. J., Costello, E. J., Angold, A., TWeed, D Stangle, D., Farmer, E. N. Z., Erkanli, A. (1995). Data watch Children s mental health service use across service sectors. Health Affairs, 13,147-159. 

Leaf, P. J, Alegria, M Cohen, R, Goodman, S. H., Horowitz, S. M., Houen, C. W., Narrow, W. E., Vaden-Kieman, M., Regeier, D. A. (1996). Mental health service use in the community and schools Results from the 4 community MECA study. Journal of American Academy of Child and Adolescent Psychiatry, 35, 889-897. 

Substance Abuse and Mental Health Services Administration Results from the 2002 National Survey on Drug Use and Health National Findings (DHHS Publ No SMA 03-3836). Rockville, MD, Substance Abuse and Mental Health Services Administration, 2003. Available at http //oas.samhsa.gov/nhsda/2k2nsduh/ Results/2k2Results.htm chap3. Accessed November 5, 2004. 

Source. From the results of the 2002 National Survey on Drug Use and Health (Substance Abuse and Mental Health Services Administration 2003). 

J Consult Clin Psychol 61 1100—1104, 1993 Stephens RS, Roffman RA, Simpson EE Treating adult marijuana dependence a test of the relapse prevention model. J Consult Clin Psychol 62 92—99, 1994 Stephens RS, Roffman RA, Curtin L Comparison of extended versus brief treatments for marijuana use. J Counsul Clin Psychol 68 898—908, 2000 Substance Abuse and Mental Health Services Administration The BASIS Report Marijuana Treatment Admissions Increase 1993-1999. Rockville, MB, Substance Abuse and Mental Health Services Administration, 2002a Substance Abuse and Mental Health Services Administration Results from the 2001 National Household Survey on Brug Abuse Vol I. Summary of National Findings. Rockville, MB, Substance Abuse and Mental Health Services Administration, 2002b... 

Substance Abuse and Mental Health Services Administration The BASIS Report Marijuana Use Secondary to Other Substances of Abuse. Rockville, MB, Substance Abuse and Mental Health Services Administration, 2003 Tanda G, Munzar P, Goldberg SR Self-administration behaviour is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nat Neurosci 3 1073— 1074, 2000... 

Thus, analyzing the individualism/collectivism construct as a cultural factor can help to explain why some ethnic groups apparently under-use mental health services and, in contrast, rely on members of the family to provide care in possible... 

Jackson, J. S., Neighbors, H. W., Torres, M. et al. (2007). Use of mental health services and subjective satisfaction with treatment among Black Caribbean immigrants results from the National Survey of American Life. Am. J. Public Health, 97( 1), 60-7. 

The cross-national prescribing database using the same methodology provided a useful and valid comparison of patterns of prescribing psychotropic medications in mental health services in Australia, Thailand, and Malaysia (Ng et al, submitted). The study was carried out in three outpatient mental health centres in North Western Mental Health (NWMH) in Melbourne (September to November 2002), Prince of Songkla University Hospital in Hat Yai (January to March 2003), and Hospital Kuala Lumpur (January to March 2003). The proportions of outpatients treated with a primary diagnosis of a psychotic illness were 91%, 41%, and 75% in the Australian, Thai, and Malaysian samples respectively. Considering psychotropic prescriptions in schizophrenia alone, the majority of patients were prescribed antipsychotics Australia (93.7%), Thailand (92.9%), and Malaysia (97.7%). 

The collaboration between mental health services and members of families of people with mental illness and their other carers is of essential importance in developing a useful and successful mental health service. Collaboration with carers is not in existence in many of the Third World countries, and in places where it exists it is at present often restricted to a one-way communication of instruction of what the carers should do to assist in the realization of the treatment plan established by the medical practitioners. Advice from carers and information about the effects of treatment can both be of great value in the treatment of individual patients and in deciding the best use of medications and other treatments in health services in general. 

Soumerai, S., et al., "Effects of Limiting Medicaid Drug Reimbursement Benefits on the Use of Psychotropic Agents and Acute Mental Health Services by Patients with Schizophrenia," N. Engl. ]. Med., 331, 650-655 (1994). 

Epidemiological research suggests that probably 10 to 20% of the population of the United States may have problems related to substance use, with approximately 5 % of the population having problems with drugs other than alcohol (Substance Abuse and Mental Health Services Administration [SAMHSA], 2003). The most widely abused substances in the United States are alcohol, tobacco, and marijuana, but the typical pattern is for a person to abuse more than one substance at a time. An example might be that a person may smoke both cigarettes and marijuana, or may use both cocaine and heroin. 

Substance Abuse and Mental Health Services Administration. (2003). Resutts from the 2002 Nationai Survey on Drug Use and Heaith Detaiied Tabies. Table 1.1B. (Office of Applied Studies, Department of Health and Human Services). Rockville, MD. http //www.samhsa.gov/oas/nhsda/ 2k2nsduh/Sect1 peTabs1to18.pdf , The number of Americans who have used marijuana in the last year (25,755,000) is greater than the entire population of Texas (20,851,820). (Ibid. And United States Census Bureau Report for 2000. Summary File 4. http //www.census.gov/)... 

The increasing use of stimulants in the United States to treat attention deficit hyperactivity disorder (ADHD) has aroused parental concern and compelled both medical professionals and the media to question the safety and efficacy of this type of treatment. Because ADHD is among the most common reasons for seeking mental health services for children, these questions are more pertinent than ever. This chapter will examine the history of stimulant use, the mechanism of action, pharmacokinetics, side effects, and issues related to their clinical use in children and adolescents. More detailed information on clinical applications is provided in Section III. 

---